Skip to content
Solved
SearchBrowse
Sign in

Contents

Official guidance
Corporate Intangibles Research and Development Manual

CIRD75000 · VRR

  • CIRD75050 · Introduction
  • CIRD75100 · Vaccine Research Relief: Requirement that Company is a going concern
  • CIRD75200 · Qualifying expenditure: for an accounting period
  • CIRD75300 · Qualifying expenditure: on direct R&D
  • CIRD75400 · Qualifying expenditure: on sub-contracted R&D
  • CIRD75500 · Qualifying expenditure: on contributions to independent R&D
  • CIRD75525 · Subcontracting to charities, universities and scientific research organisations
  • CIRD75550 · Subcontracting to companies and others
  • CIRD75600 · How relief is given: SMEs
  • CIRD75700 · How relief is given: large companies
  • CIRD75800 · How relief is given: insurance companies
  • CIRD75900 · Inflated claims
  • CIRD75950 · Refunds of contributions and subcontract payments
  • CIRD76000 · Specified diseases: general
  • CIRD76100 · Specified diseases: tuberculosis and malaria
  • CIRD76200 · Specified diseases: HIV/AIDS
  • CIRD76300 · Definitions
  • CIRD76400 · Dealing with claims
  1. VRR: contents
  2. VRR: subcontracting to charities, universities and scientific research organisations

CIRD75525 | VRR: subcontracting to charities, universities and scientific research organisations

From HM Revenue & Customs · Corporate Intangibles Research and Development Manual

FA02SCH13/PARA 6 defines qualifying expenditure on subcontracted R&D for the purposes of VRR. Paragraphs 7 to 11 of Schedule 13 FA 02 set out the conditions that must be met for that expenditure to qualify for relief.

FA02/SCH13/PARA 6(3) allowed for the conditions set out in paragraphs 7 to 11 to be disapplied for the purposes of VRR where the sub-contractor is a charity, a university or a scientific research organisation CIRD75500.

The only conditions that needed to be satisfied for payments to a charity, university or scientific research organisation to be qualifying expenditure on subcontracted R&D for VRR purposes were:

  • The expenditure must not be subsidised or be capital expenditure.

  • The expenditure must be on R&D directly undertaken by the sub-contractor on behalf of the company and must be on qualifying R&D activity.

  • The R&D activity in respect of which the expenditure is incurred is relevant R&D in relation to the company.

See CIRD75300.

Section 27 FA 2008 repealed FA02/SCH13/PARA 6(3) and expenditure incurred on or after 1 August 2008 on subcontractor payments to a charity, university or scientific research organisation must meet the conditions set out in paragraphs 7 to 11 Schedule 13 FA 02 in the same way as all other subcontractor payments.

PreviousNext
PrivacyTerms